Investigator-Initiated Trials

An Investigator-Initiated Trial (IIT) is an unsolicited pre-clinical or clinical study, interventional or observational, for which an investigator independently has submitted a proposal. Oncopeptides may provide support of different kind if a proposal is approved such as drug supply, expert advice and funding of expenses associated with the conduct of the study, in accordance with local fair market value.

Oncopeptides supports IITs as part of scientific interaction aiming to improve patient care and the practice of medicine. IITs are independently planned by Investigators so that the independence of hypothesis, design, operational execution, and reporting of IITs is guaranteed. The investigator, or the institution the investigator is associated with, will serve as the study sponsor. The overall objective of the Company´s IIT program is to advance medical and scientific knowledge related to our products or therapeutic areas.

Click here to view the areas of interest for IITs

Registration of interest

Applications for support can be done at this webpage by filling in the form underneath.
Please note that it is not possible to save a partially completed application. Click here to open a new window with a list of all questions to facilitate your application.
The information submitted to Oncopeptides will be held confidential within the company.
Please fill in all necessary information of your application (*) in order to ensure a swift and timely review.

Investigator contact information

Hospital / Institution /Organization / Study Group information

Sponsor information (according to GCP-ICH)

Study information

Study protocol synopsis

Study timelines

Previous experience as investigator in clinical studies *

Budget and drug supply requested from Oncopeptides AB *